Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01BA04	SUKUBA	G	Pemetrexed (disodium) - 500mg	500mg	Injectable lyophilised powder	34,786,563 L.L
J01DD01	STOPAREN	G	Cefotaxime (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	213,671 L.L
H02AB09	SOLU CORTEF ACT-O-VIAL	B	Hydrocortisone (sodium succinate) - 250mg	250mg	Injectable lyophilised powder for solution+diluent	421,967 L.L
M01AC02	SORAL	G	Tenoxicam - 20mg/2ml	20mg/2ml	Injectable lyophilised powder for solution+solvent	588,603 L.L
J01DH51	SYNERGIC	G	Imipenem - 500mg, Cilastatin - 500mg		Injectable powder	1,142,266 L.L
L04AC02	SIMULECT	BioTech	Basiliximab - 20mg	20mg	Injectable powder + solvent	137,661,787 L.L
L01XX02	SPECTRILA	BioTech	Asparaginase, recombinant - 10,000IU	10,000IU	Injectable powder for concentrate for solution	21,370,813 L.L
A02BC05	SOLEZOL	G	Esomeprazole - 40mg	40mg	Injectable powder for solution	301,021 L.L
H02AB04	SOLU MEDROL	B	Methylprednisolone sodium succinate - 500mg	500mg	Injectable powder for solution	718,956 L.L
H02AB04	SOLU MEDROL	B	Methylprednisolone sodium succinate - 1g	1g	Injectable powder for solution	1,444,631 L.L
J01DE01	SALAPIME	G	Cefepime - 1g	1g	Injectable powder for solution	618,168 L.L
H02AB04	SOLU MEDROL Act-O-Vial	B	Methylprednisolone sodium succinate - 40mg	40mg	Injectable powder for solution+diluent	318,491 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 20mg	20mg	Injectable powder for suspension+diluent	38,121,223 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 30mg	30mg	Injectable powder for suspension+diluent	57,182,544 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 20mg	20mg	Injectable powder for suspension+diluent	L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 30mg	30mg	Injectable powder for suspension+diluent	L.L
B05BC01	SERUFLEX MANNITOL 20% INJECTION, USP	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	402,213 L.L
B05BC01	SOLUFLEX MANNITOL 20% INJECTION, USP	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	603,320 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 45mg	45mg	Injectable solution	L.L
A10BJ02	SAXENDA	BioTech	Liraglutide - 6mg/ml	6mg/ml	Injectable solution	16,747,035 L.L
A10BJ06	SEMATIDE	G	Semaglutide - 1mg	1mg	Injectable solution	9,288,397 L.L
A10BJ06	SEMATIDE	G	Semaglutide - 0.25mg & 0.5mg		Injectable solution	9,288,397 L.L
M05BA08	SIMPLA	G	Zoledronic acid - 5mg/100ml	5mg/100ml	Injectable solution	13,071,402 L.L
N01AH03	SUFENTANIL RENAUDIN	G	Sufentanil (citrate) - 250mcg/5ml	250mcg/5ml	Injectable solution	3,524,899 L.L
N01AH03	SUFENTANIL RENAUDIN	G	Sufentanil (citrate) - 5mcg/ml	10mcg/2ml	Injectable solution	755,239 L.L
P01AB01	SOLUFLEX METRONIDAZOLE	G	Metronidazole - 500mg/100ml	500mg/100ml	Injectable solution	162,541 L.L
J06BD01	SYNAGIS	BioTech	Palivizumab - 100mg/ml	100mg/ml	Injectable solution	57,429,464 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
J06BD01	SYNAGIS	BioTech	Palivizumab - 50mg/0.5ml	50mg/0.5ml	Injectable solution	38,316,693 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L

...